Barbara James is a writer for Collider and a content creator. Currently, she works at Screen Rant as an Video Game Features Writer. As a graduate with a major in English, Barbara has worked as an ...

ELLE’s guide to the best albums of 2026 so far highlights the year’s essential releases, buzziest artists, and records you should stream next.

AI music is everywhere in 2026, but not every generator delivers on audio quality, licensing, or value. We tested the top options to help you pick the right one.

They could be two seconds long or 30; straightforward 4/4 rhythms or flights of percussive wizardry; inducers of head nodding or air drumming. They are the drum intros to classic songs, and legends ...

Content creation is rampant nowadays. People are consuming a lot of content, and to cater to them, the number of creators is increasing. Not everyone can have the chance to shoot great videos and ...

Prepare for a breathtaking journey into the origins of Merthana! Witness the rise of King Robar II and his relentless pursuit of power, only to be challenged by an unseen force. Discover how ...

Darren Aronofsky among proponents of using technology, while Guillermo del Toro says he would ‘rather die’ Under a white marquee on Cannes’ Croisette beach, with the Mediterranean glistening behind ...

Josh Groban has released his new album CINEMATIC, out now via Reprise Records. A tribute to the world of the silver screen, the 10-track album CINEMATIC honors the scores and songs that defined ...

Elemental Royalty Corporation is rated Buy, positioned as a mid-tier royalty company post-merger, with strong growth prospects and Tether's strategic backing. Tether's involvement provides ELE with ...

Directing movies is also a matter of production—of the interpersonal, the administrative, and the technical practicalities that go into creating the images and sounds that end up on the screen. The ...

Royalty Pharma has made another play in the autoimmune space, this time crowning Johnson & Johnson as the beneficiary. Royalty and J&J have agreed to co-fund the development of a chronic autoimmune ...